Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00553969 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 101
- Enrollment target
NCT00553969 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 101 participants.
The verdict
NCT00553969, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 101 participants
- Enrollment target
Study Summary
This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures that do not require anti-hypertensive therapy and at least one additional cardiovascular risk factor.
Interventions
- DRUG lisinopril
- DRUG carvedilol phosphate
- DRUG carvedilol phosphate and lisinopril
- DRUG placebo and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00553969
The ClinicalTrials.gov registry entry for NCT00553969 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which lisinopril is the first listed.
NCT00553969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00553969 about?
NCT00553969 is a clinical study titled "Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease". This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures ...
What is the current status of trial NCT00553969?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 101 participants. The study started on 2007-11. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00553969?
The interventions under investigation include: lisinopril (DRUG), carvedilol phosphate (DRUG), carvedilol phosphate and lisinopril (DRUG), placebo and placebo (DRUG).
Who is sponsoring clinical trial NCT00553969?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.